Nuclear Medicine/Radiopharmaceutical US Market Research Report 2021
The global Nuclear Medicine & Radiopharmaceuticals market is
segmented by company, region (country), by Type, and by Application. Players,
stakeholders, and other participants in the global Nuclear Medicine & Radiopharmaceuticals
market will be able to gain the upper hand as they use the report as a powerful
resource. The segmental analysis focuses on sales, revenue and forecast by
region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Diagnostic
Therapeutic
Segment by Application
Oncology
Thyroid
Cardiology
The Nuclear Medicine & Radiopharmaceuticals market is
analysed and market size information is provided by regions (countries).
Segment by Application, the Nuclear Medicine & Radiopharmaceuticals market
is segmented into North America, Europe, China, Japan, Southeast Asia, India
and Other Regions.
By Company
China Isotope & Radiation
Dongcheng
Jaco
Ciaeriar
Advanced Molecular-imaging Solution
Shanghai Atom Kexing
Table of Contents
1 Nuclear Medicine & Radiopharmaceuticals Market Overview
1.1 Nuclear Medicine & Radiopharmaceuticals Product Scope
1.2 Nuclear Medicine & Radiopharmaceuticals Segment by Type
1.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales by Type (2016
& 2021 & 2027)
1.2.2 Diagnostic
1.2.3 Therapeutic
1.3 Nuclear Medicine & Radiopharmaceuticals Segment by Application
1.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Comparison by
Application (2016 & 2021 & 2027)
1.3.2 Oncology
1.3.3 Thyroid
1.3.4 Cardiology
1.4 Nuclear Medicine & Radiopharmaceuticals Market Estimates and Forecasts
(2016-2027)
1.4.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size in Value
Growth Rate (2016-2027)
1.4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Size in Volume
Growth Rate (2016-2027)
1.4.3 Global Nuclear Medicine & Radiopharmaceuticals Price Trends
(2016-2027)
2 Nuclear Medicine & Radiopharmaceuticals Estimates and
Forecasts by Region
2.1 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Region:
2016 VS 2021 VS 2027
2.2 Global Nuclear Medicine & Radiopharmaceuticals Retrospective Market
Scenario by Region (2016-2021)
2.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by
Region (2016-2021)
2.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share
by Region (2016-2021)
2.3 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and
Forecasts by Region (2022-2027)
2.3.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Estimates and
Forecasts by Region (2022-2027)
2.3.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by
Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Nuclear Medicine & Radiopharmaceuticals Estimates and
Projections (2016-2027)
2.4.2 Europe Nuclear Medicine & Radiopharmaceuticals Estimates and
Projections (2016-2027)
2.4.3 China Nuclear Medicine & Radiopharmaceuticals Estimates and
Projections (2016-2027)
2.4.4 Japan Nuclear Medicine & Radiopharmaceuticals Estimates and
Projections (2016-2027)
2.4.5 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Estimates and
Projections (2016-2027)
2.4.6 India Nuclear Medicine & Radiopharmaceuticals Estimates and
Projections (2016-2027)
3 Global Nuclear Medicine & Radiopharmaceuticals Competition Landscape by
Players
3.1 Global Top Nuclear Medicine & Radiopharmaceuticals Players by Sales
(2016-2021)
3.2 Global Top Nuclear Medicine & Radiopharmaceuticals Players by Revenue
(2016-2021)
3.3 Global Nuclear Medicine & Radiopharmaceuticals Market Share by Company
Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nuclear
Medicine & Radiopharmaceuticals as of 2020)
3.4 Global Nuclear Medicine & Radiopharmaceuticals Average Price by Company
(2016-2021)
3.5 Manufacturers Nuclear Medicine & Radiopharmaceuticals Manufacturing
Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Type
4.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Review
by Type (2016-2021)
4.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by
Type (2016-2021)
4.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share
by Type (2016-2021)
4.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Type (2016-2021)
4.2 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and
Forecasts by Type (2022-2027)
4.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Type
(2022-2027)
4.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by
Type (2022-2027)
4.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by Type
(2022-2027)
5 Global Nuclear Medicine & Radiopharmaceuticals Market Size by Application
5.1 Global Nuclear Medicine & Radiopharmaceuticals Historic Market Review
by Application (2016-2021)
5.1.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Market Share by
Application (2016-2021)
5.1.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Market Share
by Application (2016-2021)
5.1.3 Global Nuclear Medicine & Radiopharmaceuticals Price by Application
(2016-2021)
5.2 Global Nuclear Medicine & Radiopharmaceuticals Market Estimates and
Forecasts by Application (2022-2027)
5.2.1 Global Nuclear Medicine & Radiopharmaceuticals Sales Forecast by Application
(2022-2027)
5.2.2 Global Nuclear Medicine & Radiopharmaceuticals Revenue Forecast by
Application (2022-2027)
5.2.3 Global Nuclear Medicine & Radiopharmaceuticals Price Forecast by
Application (2022-2027)
6 North America Nuclear Medicine & Radiopharmaceuticals
Market Facts & Figures
6.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by Company
6.1.1 North America Nuclear Medicine & Radiopharmaceuticals Sales by
Company (2016-2021)
6.1.2 North America Nuclear Medicine & Radiopharmaceuticals Revenue by
Company (2016-2021)
6.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Type
6.2.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Type (2016-2021)
6.2.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Type (2022-2027)
6.3 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Application
6.3.1 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Application (2016-2021)
6.3.2 North America Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Application (2022-2027)
7 Europe Nuclear Medicine & Radiopharmaceuticals Market
Facts & Figures
7.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Company
7.1.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales by Company
(2016-2021)
7.1.2 Europe Nuclear Medicine & Radiopharmaceuticals Revenue by Company
(2016-2021)
7.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
7.2.1 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Type (2016-2021)
7.2.2 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Type (2022-2027)
7.3 Europe Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Application
7.3.1 Europe 139 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 139 Sales Breakdown by Application (2022-2027)
8 China Nuclear Medicine & Radiopharmaceuticals Market Facts
& Figures
8.1 China Nuclear Medicine & Radiopharmaceuticals Sales by Company
8.1.1 China Nuclear Medicine & Radiopharmaceuticals Sales by Company
(2016-2021)
8.1.2 China Nuclear Medicine & Radiopharmaceuticals Revenue by Company
(2016-2021)
8.2 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
8.2.1 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
(2016-2021)
8.2.2 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
(2022-2027)
8.3 China Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Application
8.3.1 China 244 Sales Breakdown by Application (2016-2021)
8.3.2 China 244 Sales Breakdown by Application (2022-2027)
9 Japan Nuclear Medicine & Radiopharmaceuticals Market Facts
& Figures
9.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales by Company
9.1.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales by Company
(2016-2021)
9.1.2 Japan Nuclear Medicine & Radiopharmaceuticals Revenue by Company
(2016-2021)
9.2 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
9.2.1 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
(2016-2021)
9.2.2 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
(2022-2027)
9.3 Japan Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Application
9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Nuclear Medicine & Radiopharmaceuticals
Market Facts & Figures
10.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by
Company
10.1.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales by
Company (2016-2021)
10.1.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Revenue by
Company (2016-2021)
10.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Type
10.2.1 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales
Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales
Breakdown by Type (2022-2027)
10.3 Southeast Asia Nuclear Medicine & Radiopharmaceuticals Sales Breakdown
by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Nuclear Medicine & Radiopharmaceuticals Market
Facts & Figures
11.1 India Nuclear Medicine & Radiopharmaceuticals Sales by Company
11.1.1 India Nuclear Medicine & Radiopharmaceuticals Sales by Company
(2016-2021)
11.1.2 India Nuclear Medicine & Radiopharmaceuticals Revenue by Company
(2016-2021)
11.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by Type
11.2.1 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Type (2016-2021)
11.2.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Type (2022-2027)
11.3 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Application
11.3.1 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Application (2016-2021)
11.3.2 India Nuclear Medicine & Radiopharmaceuticals Sales Breakdown by
Application (2022-2027)
12 Company Profiles and Key Figures in Nuclear Medicine &
Radiopharmaceuticals Business
12.1 China Isotope & Radiation
12.1.1 China Isotope & Radiation Corporation Information
12.1.2 China Isotope & Radiation Business Overview
12.1.3 China Isotope & Radiation Nuclear Medicine & Radiopharmaceuticals
Sales, Revenue and Gross Margin (2016-2021)
12.1.4 China Isotope & Radiation Nuclear Medicine &
Radiopharmaceuticals Products Offered
12.1.5 China Isotope & Radiation Recent Development
12.2 Dongcheng
12.2.1 Dongcheng Corporation Information
12.2.2 Dongcheng Business Overview
12.2.3 Dongcheng Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and
Gross Margin (2016-2021)
12.2.4 Dongcheng Nuclear Medicine & Radiopharmaceuticals Products Offered
12.2.5 Dongcheng Recent Development
12.3 Jaco
12.3.1 Jaco Corporation Information
12.3.2 Jaco Business Overview
12.3.3 Jaco Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and
Gross Margin (2016-2021)
12.3.4 Jaco Nuclear Medicine & Radiopharmaceuticals Products Offered
12.3.5 Jaco Recent Development
12.4 Ciaeriar
12.4.1 Ciaeriar Corporation Information
12.4.2 Ciaeriar Business Overview
12.4.3 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Sales, Revenue and
Gross Margin (2016-2021)
12.4.4 Ciaeriar Nuclear Medicine & Radiopharmaceuticals Products Offered
12.4.5 Ciaeriar Recent Development
12.5 Advanced Molecular-imaging Solution
12.5.1 Advanced Molecular-imaging Solution Corporation Information
12.5.2 Advanced Molecular-imaging Solution Business Overview
12.5.3 Advanced Molecular-imaging Solution Nuclear Medicine &
Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Advanced Molecular-imaging Solution Nuclear Medicine &
Radiopharmaceuticals Products Offered
12.5.5 Advanced Molecular-imaging Solution Recent Development
12.6 Shanghai Atom Kexing
12.6.1 Shanghai Atom Kexing Corporation Information
12.6.2 Shanghai Atom Kexing Business Overview
12.6.3 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals Sales,
Revenue and Gross Margin (2016-2021)
12.6.4 Shanghai Atom Kexing Nuclear Medicine & Radiopharmaceuticals
Products Offered
12.6.5 Shanghai Atom Kexing Recent Development
...
13 Nuclear Medicine & Radiopharmaceuticals Manufacturing
Cost Analysis
13.1 Nuclear Medicine & Radiopharmaceuticals Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
....continued
CONTACT DETAILS
+44 203 500 2763
+1 62 825 80070
971 0503084105
Comments
Post a Comment